INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights

Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S. Food and Drug Administration (FDA)...

May 14, 2026 - 01:00
 0  1
INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S. Food and Drug Administration (FDA)...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow